83 related articles for article (PubMed ID: 10203038)
21. Studies on V3-specific cross-reactive T-cell responses in chimpanzees chronically infected with HIV-1IIIB.
Nehete PN; Murthy KK; Satterfield WC; Arlinghaus RB; Sastry KJ
AIDS; 1995 Jun; 9(6):567-72. PubMed ID: 7662194
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy.
Faith A; O'Hehir RE; Malkovsky M; Lamb JR
Immunology; 1992 Jun; 76(2):177-84. PubMed ID: 1353060
[TBL] [Abstract][Full Text] [Related]
23. The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigens.
Sheikh MJ; Ongrádi J; Austen BM; Dalgleish AG
AIDS; 1995 Nov; 9(11):1229-35. PubMed ID: 8561975
[TBL] [Abstract][Full Text] [Related]
24. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production.
Manca F; Seravalli E; Valle MT; Fenoglio D; Kunkl A; Li Pira G; Zolla-Pazner S; Celada F
Int Immunol; 1993 Sep; 5(9):1109-17. PubMed ID: 7902128
[TBL] [Abstract][Full Text] [Related]
25. Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells.
Trujillo JR; Rogers RA; Brain JD
Virology; 1998 Jun; 246(1):53-62. PubMed ID: 9656993
[TBL] [Abstract][Full Text] [Related]
26. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
[TBL] [Abstract][Full Text] [Related]
27. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
28. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers.
Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877
[TBL] [Abstract][Full Text] [Related]
29. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection.
Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F
J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041
[TBL] [Abstract][Full Text] [Related]
30. An immunological comparison between lipidated and non-lipidated multivalent HIV-1 peptides representing Gp120 and Gag hypervariable regions.
Ghunaim H; Kumar A; Torres J; Diaz-Mitoma F; Azizi A
Vaccine; 2011 Aug; 29(35):5950-8. PubMed ID: 21718739
[TBL] [Abstract][Full Text] [Related]
31. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
33. gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease.
Skowron G; Cole BF; Zheng D; Accetta G; Yen-Lieberman B
AIDS; 1997 Dec; 11(15):1807-14. PubMed ID: 9412698
[TBL] [Abstract][Full Text] [Related]
34. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
[TBL] [Abstract][Full Text] [Related]
36. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
37. Ligation of either CD2 or CD28 rescues CD4+ T cells from HIV-gp120-induced apoptosis.
Tuosto L; Piazza C; Moretti S; Modesti A; Greenlaw R; Lechler R; Lombardi G; Piccolella E
Eur J Immunol; 1995 Oct; 25(10):2917-22. PubMed ID: 7589092
[TBL] [Abstract][Full Text] [Related]
38. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
[TBL] [Abstract][Full Text] [Related]
39. Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.
Jurcevic S; Praud C; Coppin HL; Bertrand A; Ricard S; Thomsen M; Lakhdar-Ghazal F; De Preval C
Immunology; 1996 Mar; 87(3):414-20. PubMed ID: 8778027
[TBL] [Abstract][Full Text] [Related]
40. Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.
Peifang S; Pira GL; Fenoglio D; Harris S; Costa MG; Venturino V; Dessì V; Layton G; Laman J; Huisman JG
Clin Exp Immunol; 1994 Sep; 97(3):361-6. PubMed ID: 7915974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
